Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152,309,909
-
Total 13F shares
-
37,209,172
-
Share change
-
-342,887
-
Total reported value
-
$12,897,621,890
-
Put/Call ratio
-
50%
-
Price per share
-
$346.64
-
Number of holders
-
534
-
Value change
-
-$179,595,754
-
Number of buys
-
230
-
Number of sells
-
281
Institutional Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q2 2022
As of 30 Jun 2022,
BIO-TECHNE Corp - COMMON STOCK (TECH) was held by
534 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,209,172 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, BAMCO INC /NY/, Select Equity Group, L.P., Neuberger Berman Group LLC, BROWN CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, Winslow Capital Management, LLC, and DF DENT & CO INC.
This page lists
534
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.